CC-4047 in Treating Patients With Myelofibrosis

Summary

RATIONALE: Biological therapies, such as CC-4047, may stimulate the immune system in different ways and stop cancer cells from growing. CC-4047 may also stop the growth of cancer cells by blocking blood flow to the cancer. PURPOSE: This trial is studying the side effects and best dose of CC-4047 and to see how well it works in treating patients with myelofibrosis.

Timeline

Start

2008-05

Primary completion

2010-07-07

Completion

2019-12-12

Drugs

Indications